A carregar...
Ranolazine for Congenital Long QT Syndrome Type III (LQT3): Experimental and Long-Term Clinical Data
BACKGROUND: The basic defect in long QT syndrome type-III (LQT3) is an excessive inflow of sodium current during phase-3 of the action potential caused by mutations in the SCN5A gene. Most sodium channel blockers reduce the early (peak) and late components of the sodium current (I(Na) and I(NaL)) bu...
Na minha lista:
| Publicado no: | Circ Arrhythm Electrophysiol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119553/ https://ncbi.nlm.nih.gov/pubmed/27733495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.116.004370 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|